These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

642 related items for PubMed ID: 19064984

  • 1. Analysis of risk factors for outcomes after unrelated cord blood transplantation in adults with lymphoid malignancies: a study by the Eurocord-Netcord and lymphoma working party of the European group for blood and marrow transplantation.
    Rodrigues CA, Sanz G, Brunstein CG, Sanz J, Wagner JE, Renaud M, de Lima M, Cairo MS, Fürst S, Rio B, Dalley C, Carreras E, Harousseau JL, Mohty M, Taveira D, Dreger P, Sureda A, Gluckman E, Rocha V.
    J Clin Oncol; 2009 Jan 10; 27(2):256-63. PubMed ID: 19064984
    [Abstract] [Full Text] [Related]

  • 2. Outcomes of Cord Blood Transplantation Using Reduced-Intensity Conditioning for Chronic Lymphocytic Leukemia: A Study on Behalf of Eurocord and Cord Blood Committee of Cellular Therapy and Immunobiology Working Party, Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation, and the Societé Française de Greffe de Moelle et Therapie Cellulaire.
    Xavier E, Cornillon J, Ruggeri A, Chevallier P, Cornelissen JJ, Andersen NS, Maillard N, Nguyen S, Blaise D, Deconinck E, Veelken H, Milpied N, Van Gelder M, Peffault de Latour R, Gluckman E, Kröger N, Schetelig J, Rocha V.
    Biol Blood Marrow Transplant; 2015 Aug 10; 21(8):1515-23. PubMed ID: 25958294
    [Abstract] [Full Text] [Related]

  • 3. [Allogeneic transplantation in malignant lymphoma].
    Stötzer OJ, Schleuning M, Ledderose G, Hiddemann W, Kolb HJ.
    Dtsch Med Wochenschr; 2001 Sep 28; 126(39):1062-9. PubMed ID: 11602913
    [Abstract] [Full Text] [Related]

  • 4. Unrelated umbilical cord blood transplantation for adults with haematological malignancies: results from a single Australian centre.
    Bradstock KF, Hertzberg MS, Kerridge IH, Svennilson J, McGurgan M, Huang G, Antonenas V, Gottlieb DJ.
    Intern Med J; 2006 Jun 28; 36(6):355-61. PubMed ID: 16732860
    [Abstract] [Full Text] [Related]

  • 5. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
    Warlick ED, Cioc A, Defor T, Dolan M, Weisdorf D.
    Biol Blood Marrow Transplant; 2009 Jan 28; 15(1):30-8. PubMed ID: 19135940
    [Abstract] [Full Text] [Related]

  • 6. Umbilical cord blood transplantation in adults: results of the prospective Cord Blood Transplantation (COBLT).
    Cornetta K, Laughlin M, Carter S, Wall D, Weinthal J, Delaney C, Wagner J, Sweetman R, McCarthy P, Chao N.
    Biol Blood Marrow Transplant; 2005 Feb 28; 11(2):149-60. PubMed ID: 15682076
    [Abstract] [Full Text] [Related]

  • 7. Comparison of reduced-intensity and conventional myeloablative regimens for allogeneic transplantation in non-Hodgkin's lymphoma.
    Rodriguez R, Nademanee A, Ruel N, Smith E, Krishnan A, Popplewell L, Zain J, Patane K, Kogut N, Nakamura R, Sarkodee-Adoo C, Forman SJ.
    Biol Blood Marrow Transplant; 2006 Dec 28; 12(12):1326-34. PubMed ID: 17162215
    [Abstract] [Full Text] [Related]

  • 8. Results of genoidentical hemopoietic stem cell transplantation with reduced intensity conditioning for acute myelocytic leukemia: higher doses of stem cells infused benefit patients receiving transplants in second remission or beyond--the Acute Leukemia Working Party of the European Cooperative Group for Blood and Marrow Transplantation.
    Gorin NC, Labopin M, Boiron JM, Theorin N, Littlewood T, Slavin S, Greinix H, Cahn JY, Alessandrino EP, Rambaldi A, Nagler A, Polge E, Rocha V, Acute Leukemia Working Party of the European Cooperative Group for Blood and Marrow Transplantation.
    J Clin Oncol; 2006 Aug 20; 24(24):3959-66. PubMed ID: 16880451
    [Abstract] [Full Text] [Related]

  • 9. Reduced-intensity conditioning compared with conventional allogeneic stem-cell transplantation in relapsed or refractory Hodgkin's lymphoma: an analysis from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.
    Sureda A, Robinson S, Canals C, Carella AM, Boogaerts MA, Caballero D, Hunter AE, Kanz L, Slavin S, Cornelissen JJ, Gramatzki M, Niederwieser D, Russell NH, Schmitz N.
    J Clin Oncol; 2008 Jan 20; 26(3):455-62. PubMed ID: 18086796
    [Abstract] [Full Text] [Related]

  • 10. Unrelated cord blood transplantation after myeloablative conditioning in adults with acute myelogenous leukemia.
    Ooi J, Takahashi S, Tomonari A, Tsukada N, Konuma T, Kato S, Kasahara S, Sato A, Monma F, Nagamura F, Iseki T, Tojo A, Asano S.
    Biol Blood Marrow Transplant; 2008 Dec 20; 14(12):1341-7. PubMed ID: 19041055
    [Abstract] [Full Text] [Related]

  • 11. Long-term outcomes in adults with leukemia treated with transplantation of two unrelated umbilical cord blood units.
    Yin Y, Ren HY, Cen XA, Qiu ZX, Ou JP, Wang WS, Wang MJ, Xu WL, Wang LH, Li Y, Dong YJ.
    Chin Med J (Engl); 2011 Aug 20; 124(16):2411-6. PubMed ID: 21933579
    [Abstract] [Full Text] [Related]

  • 12. Clinical outcomes of unrelated donor umbilical cord blood transplantation for 30 adults with hematological malignancies.
    Kobayashi K, Maeda Y, Hara Y, Nishie-Kataoka M, Nishimori H, Sugiyama H, Namba N, Kubonishi S, Niiya M, Shinagawa K, Ikeda K, Tanimoto M.
    Anticancer Res; 2009 May 20; 29(5):1763-70. PubMed ID: 19443401
    [Abstract] [Full Text] [Related]

  • 13. Early hematopoietic recovery after single unit unrelated cord blood transplantation in adults supported by co-infusion of mobilized stem cells from a third party donor.
    Magro E, Regidor C, Cabrera R, Sanjuán I, Forès R, Garcia-Marco JA, Ruiz E, Gil S, Bautista G, Millán I, Madrigal A, Fernandez MN.
    Haematologica; 2006 May 20; 91(5):640-8. PubMed ID: 16670070
    [Abstract] [Full Text] [Related]

  • 14. [Unrelated umbilical cord blood transplantation with TBI/Ara-c/CY non-ATG conditioning regimen for adults with hematologic malignancies].
    Sun ZM, Liu HL, Geng LQ, Zhou CY, Wang XB, Ding KY, Tong J, Zhu WB, Liu X, Wang ZY.
    Zhonghua Yi Xue Za Zhi; 2012 Jun 26; 92(24):1660-4. PubMed ID: 22944153
    [Abstract] [Full Text] [Related]

  • 15. Successful prevention of acute graft-versus-host disease using low-dose antithymocyte globulin after mismatched, unrelated, hematopoietic stem cell transplantation for acute myelogenous leukemia.
    Kim HJ, Min WS, Cho BS, Eom KS, Kim YJ, Min CK, Lee S, Cho SG, Jin JY, Lee JW, Kim CC.
    Biol Blood Marrow Transplant; 2009 Jun 26; 15(6):704-17. PubMed ID: 19450755
    [Abstract] [Full Text] [Related]

  • 16. Unrelated umbilical cord blood transplantation using a TBI/FLAG conditioning regimen for adults with hematologic malignancies.
    Okada M, Fujimori Y, Misawa M, Kai S, Nakajima T, Okikawa Y, Satake A, Itoi H, Takatsuka H, Itsukuma T, Nishioka K, Tamaki H, Ikegame K, Hara H, Ogawa H.
    Biol Blood Marrow Transplant; 2008 Aug 26; 14(8):896-903. PubMed ID: 18640573
    [Abstract] [Full Text] [Related]

  • 17. Influence of nucleated cell dose on overall survival of unrelated cord blood transplantation for patients with severe acquired aplastic anemia: a study by eurocord and the aplastic anemia working party of the European group for blood and marrow transplantation.
    Peffault de Latour R, Purtill D, Ruggeri A, Sanz G, Michel G, Gandemer V, Maury S, Kurtzberg J, Bonfim C, Aljurf M, Gluckman E, Socié G, Passweg J, Rocha V.
    Biol Blood Marrow Transplant; 2011 Jan 26; 17(1):78-85. PubMed ID: 20561593
    [Abstract] [Full Text] [Related]

  • 18. Outcomes of unrelated cord blood transplantation in pediatric recipients.
    Styczynski J, Cheung YK, Garvin J, Savage DG, Billote GB, Harrison L, Skerrett D, Wolownik K, Wischhover C, Hawks R, Bradley MB, Del Toro G, George D, Yamashiro D, van de Ven C, Cairo MS.
    Bone Marrow Transplant; 2004 Jul 26; 34(2):129-36. PubMed ID: 15107815
    [Abstract] [Full Text] [Related]

  • 19. Reduced-intensity conditioning regimen using low-dose total body irradiation before allogeneic transplant for hematologic malignancies: Experience from the European Group for Blood and Marrow Transplantation.
    Belkacémi Y, Labopin M, Hennequin C, Hoffstetter S, Mungai R, Wygoda M, Lundell M, Finke J, Aktinson C, Lorchel F, Durdux C, Basara N.
    Int J Radiat Oncol Biol Phys; 2007 Feb 01; 67(2):544-51. PubMed ID: 17141976
    [Abstract] [Full Text] [Related]

  • 20. Predictors of improved progression-free survival after nonmyeloablative allogeneic stem cell transplantation for advanced chronic lymphocytic leukemia.
    Brown JR, Kim HT, Li S, Stephans K, Fisher DC, Cutler C, Ho V, Lee SJ, Milford EL, Ritz J, Antin JH, Soiffer RJ, Gribben JG, Alyea EP.
    Biol Blood Marrow Transplant; 2006 Oct 01; 12(10):1056-64. PubMed ID: 17084369
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.